August 07, 2017

PPPI's New Exclusive Yocan Technology Vaporizer: ZEUS Builds Upon the Amazing Functionality of the Evolve Plus

When Yocan Technology introduced their Evolve Plus model last year, it was an instant hit among those looking for a high-quality portable vaporizer at an affordable price. This vaporizer was designed by the leader in concentrate vaporizers to maintain the same quality level of the original Evolve generation pens with additional functional features, and many users were impressed by the Evolve Plus' long-lasting battery life, innovative coil technology, almost instantaneous heat-up, smooth flavor and stylish design. What more could you want from such a reasonably-priced vape pen?

As it turns out, Yocan Technology figured out a way to improve upon their already-outstanding Evolve Plus model. The brand new Zeus pen vaporizer, designed by Puff Puff Pass It and offered exclusively to our customers, includes all the helpful, innovative features of the Evolve Plus with the same high-quality build--but with some great new added upgrades to make the portable vaping experience even better. As seen on Touch of Modern--the premier curated, discovery-based online shopping site that highlights the most innovative and well-designed products--Zeus vaporizer is already impressing with its new original features combined with its elegant, stylish appearance.

The Upgraded Features of PPPI's Exclusive Zeus Vaporizer

  • Magnetic Snap-On Mouthpiece

Designed to make loading the vaporizer even easier, Zeus introduces a magnetic snap-on mouthpiece. All you'll need to do is pull the mouthpiece off of Zeus vaporizer to reveal the chamber, fill with your product and let the mouthpiece snap back into place--it's that simple. Thanks to the mouthpiece's strong and durable magnets, you'll save time and effort as you load your Zeus, making the experience that much smoother.

  • New Sleek Colors

The Evolve Plus was known for its attractive colors, ranging from stylish silver to vivid orange. Zeus builds upon this reputation for eye-catching design by introducing two new colors: brass gold and brass bronze. None of Yocan Technology's other models are available in these two exclusive colors, giving Zeus another aesthetic advantage.

  • Standard Quartz Dual and Ceramic Donut Coils

Every Zeus kit comes with two coils: one ceramic donut coil and one quartz dual coil. This is a big change from the Evolve Plus, which came with just quartz dual coils. Why is this significant? The fact that Zeus comes with both types of coils standard lets users try out each type more easily and decide which is the best match to maximize their vaping experience. The previously standard coil--Yocan Technology's Quartz Dual Coil (QDC)--has been renowned for providing a clean, smooth experience. This technology evenly heats the product, allowing for intense and clear flavor combined with dense, rich vapor. On the other hand, some users find the taste provided by a ceramic donut coil superior, with the design allowing for less material waste. With Zeus, you'll be able to try out each coil type and determine for yourself which one you prefer.

In addition to its incredible improvements, Yocan Technology's new Zeus model will let you enjoy all of the same vaping features as the Evolve Plus, ensuring that you don't lose any functionality by upgrading. Zeus vaporizer employs the same 1100 mah battery with 15-second shut off, providing long battery life when you're on the road--combined with the same micro USB charger that can connect either to a wall adapter or computer for easy and convenient charging. The Evolve Plus' patented built-in silicone storage jar--one of its most innovative features--has also been carried over. This integrated storage compartment screws directly underneath the battery, eliminating the need to carry a separate bulky silicone storage container with you; this little feature is one of the key reasons that these vaporizers are among the most portable and easy-to-transport on the market.

In short, Yocan Technology's Zeus vaporizer is an excellent, innovative portable vaping device, perfect both for current Evolve Plus users and for those who are completely new to this leading brand's line of vaporizers. Zeus' added features will upgrade your experience, and its sleek, small size designed for discreet portability make it the perfect choice for becoming your new go-to device--whether you're on the road or at home.

July 04, 2017

April 19, 2017

It's That time of the year again ... 4/20 Time!

Enjoy the video.

Model: @xxbleedgoldxx

Video: @Madero_Films

April 23, 2016

2016 Best Pen with Dual Quartz Coils : Yocan Evolve

Yocan technology introduced one of the best wax pen vaporizers, "Evolve" pen. It’s a portable pen style personal vaporizer for your wax or shatter. It comes equipped with their latest breakthrough in coil technology. The QDC or Quartz Dual Coil are crafted with Quartz instead of the more conventional ceramic to provide a crystal clean and smooth vaping experience. Built with portability and convenience in mind, it also includes innovative features like a coil cap to help reduce heat transfer to the mouth piece and prevent any oil from leaking out. The built in 650mah battery ensures long life so you’ll get the most out of this compact device. With a near instant heat up and a 10 second cutoff time it’s guaranteed to satisfy all your portable vaping needs.

To complement your lifestyle, they have made it available in five attractive colors including silver, black, red, blue and orange. Stylish, sleek and unique at 14 millimeters wide and 120 millimeters long the exquisitely designed Evolve fits perfectly in your hand or pocket. Priced at just $24.99 the Evolve is both portable and affordable. Its elegant yet discreet size and simple operation makes it the ultimate device for taking with you on the go.

January 15, 2016

The Difference Between Hemp Oil and High-CBD Strains.

Over the course of the past year, cannabidiol, or CBD oil, has quickly become the rock star of the medical marijuana industry because of its ability to treat a variety of conditions -- including epilepsy -- without exposing patients to intoxicating effects. 
However, the cannabinoid is still illegal in most of the United States, which has provided an opportunity for some hemp businesses to market a variation of knockoff CBD treatments that they claim have the same healing power as popular strains such as Charlotte’s Web.
However, after patients began submitting complaints about some of these products, including “Real Scientific Hemp Oil,” claiming they were making them sick, a research firm dedicated to cannabidiol education – called Project CBD – launched a full-blown investigation into the matter. After six months, the organization emerged with a 30-page report entitled “Hemp Oil Hustlers: A Project CBD Special Report on Medical Marijuana Inc., HempMeds and Kannaway,” which began as a curious look into an umbrella penny stock company, but transformed into a dissection of the hemp oil industry and its sometimes shady business practices.
Interestingly, Project CBD found that all three companies featured in the report are operated by the same controlling interest, and shows that Kannaway and HempMeds are both subsidiaries of Medical Marijuana Inc. These companies are infamous for making claims about their legal hemp oils being significant sources for CBD because they are derived from imported hemp paste – implying that legal hemp oils are a suitable alternative to CBD medicine.
Yet, as the report indicates, these products are only technically similar and do not provide the same health benefits as high-CBD cannabis strains. “We believe that industrial hemp is not an optimal source of CBD, but it can be a viable source of CBD if certain hemp cultivators are grown organically in good soil and safe extraction and refinement methods are employed,” wrote the authors of the Project CBD report. 
Mike Adams writes for stoners and smut enthusiasts in HIGH TIMES, Playboy’s The Smoking Jacket and Hustler Magazine. You can follow him on Twitter @adamssoup and on Facebook/mikeadams73.
(Photo via Medical Jane)
October 15, 2015


Statistics show that breast cancer is the most common tumor among women and accounts for 22.9% of all cancers in women across the globe. In 2008, breast cancer was reported as the cause of over 450,000 deaths worldwide.


The therapeutic potential of cannabinoids – the medical compounds found in marijuana – in the treatment of cancer has only been discovered recently. Since the late 1990s, numerous preclinical studies have demonstrated the antitumor effects of cannabinoids in a variety of cancers.


Numeorus Studies show that cannabinoid receptors are over-expressed in the tumor cells of certain cancers, such as cancers of the liver, lung, prostate and breast. Thus, researchers have been led to believe that the endocannabinoid system may be up-regulated in cancer in an innate biological effort to fight off this disease.

Studies also show that when cannabinoids are administered and bind to these receptors, they are able to inhibit cancer cell growth by preventing the proliferation of cancer cells and by inducing cancer cell death (apoptosis). Furthermore, cannabinoids have been found to impair both tumor angiogenesis – the increase in localized blood flow induced by tumor cells – and metastasis – the spreading of cancer to other organs.


There has been great medical advancements in breast cancer in recent decades, but certain breast tumors continue to be resistant to conventional treatments. Breast cancer is comprised of tumors that are distinct in their molecular profiles, leading medical professionals to categorize the disease into 3 main subtypes.

Research suggests that synthetic cannabinoids and phytocannabinoids (mainly THC and CBD) may be useful in treating all 3 subtypes of breast cancer, with the strongest evidence of therapeutic potential pointing to treatment of HER2-positive and triple-negative breast tumors. The therapeutic potential of cannabinoids is particularly important for patients with triple-negative breast cancer, as there is no standard therapy that currently exists and prognosis for this group of patients is poor.

In addition to their anti-cancer effects, research also shows that cannabinoids are considerably safer and less toxic than conventional treatments. Cannabinoids are non-toxic to non-tumor cells and are well tolerated by patients – only eliciting relatively mild side-effects such as dizziness and fatigue.
“This compound offers the hope of a non-toxic therapy that could achieve the same results without any of the painful side effects.” – Dr. Sean McAllister

In 2007, Dr. Sean McAllister and his team of researchers were one of the first to discover that CBD’s cancer-fighting properties could be successfully applied to breast cancer.

As it turns out, cannabinoids can provide a variety of other benefits in the treatment of cancer, including the prevention of nausea and vomiting associated with standard chemotherapeutic treatments and reduction of cancer-associated pain. Research also shows that, when combined with conventional cancer treatments, cannabinoids are able to induce a synergistic action against cancer and tumor cells, suggesting that the combination of conventional and cannabinoid-based treatments may more powerful than the administration of either treatment alone.


Scientific research on the effects of cannabinoids on breast cancer has been limited to preclinical trials involving cell cultures and animal models. Researchers believe that further preclinical trials are necessary to identify which patient population is the most appropriate for cannabinoid treatment and which cannabinoids specifically present the best therapeutic option for patients before trials can advance to the clinical stage.

Until these factors are established, it is unlikely that oncologists will be willing to prescribe cannabinoid-based medicine for the treatment of breast cancer, despite the fact that research authors continue to assert the need for health professionals to be aware of cannabinoid research.

In a recent update (2013) published in the Oncology Nursing Forum, associate editor Susan Weiss Behrend concluded:
“…cannabinoids have demonstrated anti tumor activity in preclinical breast cancer models. Practicing oncology professionals need to be aware of the clinical potential of these agents…” – Susan Weiss Behrend, RN

The good thing is that cannabinoid-based pharmaceuticals such as Marinol and Cesamet (oral capsules of synthetic THC) are widely available to cancer patients for the treatment of chemotherapy-induced nausea. As well, Sativex (a natural-cannabinoid derived mouth spray) has been approved in Canada for the treatment of cancer-associated pain.

As modern cannabinoid research flourishes and continues to provide strong evidence of the cancer-fighting effects of these compounds, patients should remain optimistic about the future of cancer research and the emerging role of marijuana-based treatments that may one day take center stage in the battle against this devastating disease.


October 13, 2015

New California medical pot regulations signed by gov

SAN FRANCISCO — A trio of bills aimed at bringing order and oversight to California’s medical marijuana industry nearly 20 years after the state led the nation in legalizing pot for medical use won Gov. Jerry Brown’s signature, his office said Friday.

The first statewide licensing and operating rules for pot growers, manufacturers of cannabis-infused products and retail weed stores comes as multiple groups try to qualify voter initiatives in 2016 that would allow adults to use marijuana recreationally.

Even before Brown approved the package of new rules, initiative sponsors had started rewriting their proposed measures to incorporate many of its elements in hopes of not alienating the governor ahead of next year’s election.

“My hope is this will be viewed as a starting point, a solid foundation on which to build from,” Assemblyman Ron Bonta, D-Oakland, the lead author of one of the bills, said Friday. “Whatever happens with recreational use, there needs to be proper regulation. This is a very strong contribution from the Legislature about what those regulations should look like.”

The Democratic governor’s endorsement of the 70-page Medical Marijuana Regulation and Safety Act hammered out by lawmakers in the closing hours of the legislative session was expected because his office crafted many of the exhaustive details.

“This new structure will make sure patients have access to medical marijuana, while ensuring a robust tracking system,” Brown said in a signing statement. “This sends a clear signal to our federal counterparts that California is implementing robust controls not only on paper, but in practice.”

The package seeks to manage medical marijuana by requiring individuals or companies engaged in any aspect of the industry to obtain at least one of 17 different licenses. It restricts the number of licenses one company could have.

California medical marijuana bills OK'd by Gov. Jerry Brown
Canna Care employee John Hough waters young marijuana plants at the medical marijuana dispensary in Sacramento, Calif., on Aug. 19, 2015. (Rich Pedroncelli, Associated Press file)


The California medical marijuana legislation includes separate licenses for indoor and outdoor cultivation, transportation, product testing, distribution and dispensaries of different sizes. It also charges various state agencies to develop guidelines for packaging, potency, pesticide use and advertising.

“Today, the Wild West era of medical cannabis came to an end, and a new era of responsible regulation has begun,” said United Food and Commercial Workers Western States Council Executive Director Jim Araby, whose union lobbied for employment standards in the bills.

In addition, the bills preserve the right of individuals to grow small amounts of medical marijuana for personal use and allows local governments to ban or tax marijuana-related businesses. Another provision commissions the University of California to study how marijuana affects driving and to recommend appropriate impaired-driver standards.

“This package proves that, for the first time, Californians can work collaboratively to develop and produce comprehensive medical marijuana regulation,” said California Police Chiefs Association President David Bejarano, whose organization opposed previous efforts to regulate medical marijuana at the state level on the theory that to do so would amount to an endorsement that pot has proven benefits.

The state is expected to start issuing licenses to medical marijuana suppliers and distributors in 2018. But Brown said state agencies given responsibility for enforcing the new laws would immediately start working on fleshing out procedures left unaddressed in the bills.

The legislation includes: Bonta’s AB266, which sets up a medical marijuana bureau; AB243 by Assemblyman Jim Wood, D-Healdsburg, which allows the state to issue licenses to pay for oversight; and SB643 by Sen. Mike McGuire, D-Healdsburg, which cracks down on clinics that specialize in issuing medical marijuana licenses for people without valid health needs.

September 21, 2015

3 Studies That Prove Vaporizers Are Good For Your Lungs

(Photo credit: Terry Ozon/Flickr)

(Photo credit: Terry Ozon/Flickr)

When it comes to the healthiest way of consuming marijuana, vaporizers seem to be the top choice for doctors and patients alike.

Smoking has long been the most common method of consuming marijuana. But, while not as harmful as cigarettes, smoking marijuana is known to be bad for your lungs.

Vaporizers now offer an alternative for those looking to avoid the negative effects of smoking. Today, these devices come in all shapes and sizes, ranging from pocket-sized pens to large stationary units.

Unfortunately, vaporizers are still quite new and not enough research exists to know if they are completely free of harm. On the other hand, despite what some critics say, studies do provide support for their health benefits.

1. Vaporizing eliminates harmful toxins.

A study published in 2007 showed vaporizing could help prevent exposure to toxins in smoke. Specifically, researchers found that vaporizers delivered the same amount of THC into the bloodstream, but less carbon monoxide compared to smoking.

The team concluded that vaporizing is likely a healthier choice, since it “produces the same biological effect as smoking cannabis, but without the harmful toxins.”

‘Vaporization as a smokeless cannabis delivery system: a pilot study.’ (Abrams et al., 2007)

2. Vaporizing leads to fewer problems.

Another 2007 study was the first to link using a vaporizer to a decrease in respiratory problems. The study, which involved both cigarette and marijuana users, found those who relied on a vaporizer reported less lung symptoms — such as “cough, phlegm, and tightness in the chest” — than those who didn’t.

Interestingly, the effect was more obvious among heavy cannabis users. The researchers concluded: “Regular users of joints, blunts, pipes, and water pipes might decrease respiratory symptoms by switching to a vaporizer.”

‘Decreased respiratory symptoms in cannabis users who vaporize.’ (Earleywine and Barnwell, 2007)

3. Switching to a vaporizer can help.

In 2010, researchers published a follow-up study that took the 2007 findings a step further. The team recruited 20 cannabis smokers with existing lung symptoms and gave them vaporizers to use for a month.

Following a month of daily use, the researchers evaluated the 20 subjects and found “meaningful improvements in respiratory function.” What’s more, according to their findings, switching to a vaporizer led to benefits in lung function that were comparable to quitting cigarettes.



September 08, 2015

US government finally admits that cannabis kills cancer cells.

The US government has thrown its weight behind the earth-shattering claims that cannabis kills cancer cells.

Everyone from hippies to conspiracy theorists and even several creditable scientists have previously argued that smoking or ingesting the herb can have medicinal benefits. Cancer kills up to 20,000 people worldwide every day, according to global health estimates.

 Health researchers for the US government claim that cannabinoids - the active ingredients in cannabis - can inhibit the illness by causing cell death and blocking key blood vessels needed by tumours to grow. They say studies in mice and rats show cannabinoids may be able to kill cancer cells - while still protecting normal cells. Key chemical ingredients in marijuana were found effective in fighting against colon cancer, liver cancer, breast cancer and several other forms of the disease. It was also suggested that cannabinoids can boost the effectiveness of chemotherapy - without any of the nasty side effects.

 A health researcher on the US government's website claimed: "Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.


Cannabis farm
Controversy: Cannabis does have medicinal health benefits, US health researchers claim


Article from:


September 01, 2015

What's so special about the new 'X-Linx' ?

Over the past few weeks, we've had quite a lot of inquiries regarding our newest addition, the X-Linx e-liquid vaporizer kit by Yocan. Here is a breakdown of some of the key features of this truly revolutionary vaporizer. 

For starters, say goodbye to your old school 510 thread ego battery connection. X-Linx is the first device that breaks the 510 connection and replaces it with genius magnetic connection. Why didn't someone think of this 5 years ago right? Well better late than never and thanks to Yocan, this simple, yet revolutionary new connection is and will be an all time game changer. 

X-Linx has a truly unique design and offers numerous features for convenient smoking experience. The mouthpiece can be replaced with any 510 drip mouth tip of your choice.

The tank's body is made of SUS304 food-grade stainless steel, which basically means it's AWESOME and durable. 

X-Linx uses an OCC element head with the use of Japanese cotton and beneath the head, it has an airflow control ring with a magnetic base which features 4 different sizes of airflow holes to control the amount of air floating through the tank. 

X-Linx offers two types of OCC heads to cater all vape enthusiasts. 1.0 ohm OCC head which ranges from 15W to 25W and a 0.5 ohm OCC head which ranges from 20W to 150W. 

The X-Linx attachment tank/atomizer has a length of only 70.6 mm and the battery has a length of 97 mm. The combination of the atomizer and the battery make a completely unique and stylish look. 

Click Here to check out more of the product images along with more specs.